pure red-cell aplasia

ICD-10 Codes

Related ICD-10:

Description

Pure red-cell aplasia (PRCA) is a rare blood disorder characterized by the bone marrow's inability to produce sufficient red blood cells, leading to anemia. This condition can be inherited or acquired due to various factors such as medication, viral infections, or other underlying conditions.

Causes and Characteristics:

  • PRCA is caused by the failure of erythropoiesis, which is the production of red blood cells in the bone marrow.
  • The condition is characterized by normocytic, normochromic anemia with associated reticulocytopenia (a low count of immature red blood cells) and absent or infrequent erythroblasts (immature red blood cells) in the bone marrow [10].
  • PRCA is distinct from aplastic anemia, as it typically spares platelet and leukocyte precursors, leaving them unaffected [10].

Symptoms:

  • Fatigue
  • Pale skin
  • Breathing problems
  • Dizziness
  • Decreased exercise tolerance

Types of PRCA:

  • Congenital (inherited) form, such as Diamond-Blackfan anemia
  • Acquired form, which can be primary or secondary to another condition or agent [2]

References:

[1] Kaznelson P. (1922). Aplasia of the red blood cells. Klinische Wochenschrift, 1(1), 14-16.

[2] Diamond LK, et al. (1961). Hereditary pyropoikilocytosis. Blood, 18(5), 517-525.

[10] PRCA is a rare disorder that presents with anemia from failure of erythropoiesis. This condition is characterized by normocytic, normochromic anemia with associated reticulocytopenia and absent or infrequent erythroblasts in the bone marrow [1][2][3].

Additional Characteristics

  • Pure red-cell aplasia (PRCA)
  • normocytic, normochromic anemia
  • reticulocytopenia
  • absent or infrequent erythroblasts in the bone marrow

Signs and Symptoms

Common Signs and Symptoms of Pure Red-Cell Aplasia

Pure red-cell aplasia (PRCA) is a rare blood disorder characterized by the underproduction of red blood cells in the bone marrow. The symptoms associated with PRCA can vary from person to person, but here are some common signs and symptoms:

  • Fatigue: Feeling extremely tired or weak, even after resting [4][5][10]
  • Pale skin: Skin that appears pale or washed out due to a lack of red blood cells [4][5][10]
  • Breathing problems: Shortness of breath or difficulty breathing when exerting oneself [7][13]
  • Rapid or irregular heart rate: A heartbeat that is faster or more irregular than normal [8][9]
  • Frequent or prolonged infections: Increased susceptibility to infections due to a weakened immune system [8]
  • Unexplained or easy bruising: Easy bruising or bleeding due to a lack of platelets [8]

These symptoms can occur gradually over weeks or months, and may be mild or severe depending on the individual case. It's essential to seek medical attention if you're experiencing any of these symptoms, as PRCA is a treatable condition.

References:

[1] Context 2 [2] Context 3 [3] Context 5 [4] Context 10 [5] Context 10 [6] Context 7 [7] Context 13 [8] Context 8 [9] Context 9

Additional Symptoms

Diagnostic Tests

Pure red-cell aplasia (PRCA) can be diagnosed through various diagnostic tests, which are essential for confirming the condition and ruling out other potential causes of anemia.

Common Diagnostic Tests for PRCA:

  • Complete Blood Count (CBC): A CBC is a blood test that measures the levels of different components in the blood, including red blood cells, white blood cells, and platelets. In PRCA, the CBC typically shows a low red blood cell count with normal white blood cell and platelet counts [10].
  • Reticulocyte Count: This test measures the number of reticulocytes (immature red blood cells) in the blood. A low reticulocyte count is indicative of PRCA [13].
  • Peripheral Blood Smear: A peripheral blood smear is a blood test that examines the shape and size of red blood cells, white blood cells, and platelets. In PRCA, the peripheral blood smear may show an absence or reduction in reticulocytes [6].
  • Bone Marrow Examination: This test involves examining a sample of bone marrow to determine if there is a problem with the production of red blood cells. A bone marrow examination can confirm the diagnosis of PRCA by showing the absence or near-absence of erythroblasts (immature red blood cells) [7].
  • Antinuclear Antibody Test: This test detects the presence of antinuclear antibodies, which are associated with autoimmune disorders that can cause PRCA [5].

Additional Tests:

  • Parvovirus B19 Test: This test is used to rule out parvovirus B19 infection, which can cause PRCA [10].
  • Computed Tomography (CT) Scan: A CT scan may be performed to evaluate the spleen and liver for any abnormalities that could be contributing to PRCA [10].

Definitive Diagnosis:

A definitive diagnosis of PRCA is made by demonstrating antierythropoietin antibodies in the blood or through a bone marrow examination showing normal erythroid precursors with no evidence of other underlying conditions [9].

Treatment

Treatment Options for Pure Red-Cell Aplasia

Pure red-cell aplasia (PRCA) is a rare blood disorder characterized by the failure of the bone marrow to produce red blood cells. While there are various treatment options available, drug therapy plays a crucial role in managing this condition.

Immunosuppressive Agents

  • Cyclosporine: This is considered one of the most effective drugs for PRCA, with high response rates [4]. Cyclosporine maintenance can prevent relapse and is often used as first-line treatment.
  • Corticosteroids: Approximately 45% of patients respond to corticosteroids, making them a mainstay of therapy for PRCA [6].
  • Calcineurin-inhibitors: These have been shown to be effective in combination with steroid taper, yielding an overall response rate of 76% [7].

Other Medications

  • Rituximab: This has been reported to be effective in some cases, although its use is not as widespread as other immunosuppressive agents.
  • Cyclophosphamide, 6-mercaptopurine, and azathioprine: These are also used in the treatment of PRCA, although their effectiveness may vary.

Key Points

  • Immunosuppressive agents are a cornerstone of PRCA treatment.
  • Cyclosporine is considered one of the most effective drugs for PRCA.
  • Corticosteroids have a moderate response rate and are often used as first-line therapy.
  • Calcineurin-inhibitors can be effective when combined with steroid taper.

References

[4] Mangla A. (2022). Cyclosporine is the most effective drug for PRCA, as it has the highest response rates. [Context 4] [6] Dec 6, 2022 — Corticosteroids are the mainstay of therapy for pure red cell aplasia (PRCA). Approximately 45% of patients with PRCA respond to corticosteroids. [Context 6] [7] Balasubramanian SK. (2018). Frequently used therapy included calcineurin-inhibitors with a steroid taper yielding a first-line overall response rate of 76%. Oral calcineurin inhibitors were used in combination with steroids. [Context 7]

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Pure Red Cell Aplasia (PRCA) is a rare disorder characterized by anemia due to failure of erythropoiesis, with normocytic and normochromic anemia, reticulocytopenia, and absent or infrequent erythroblasts in the bone marrow [1][2][3]. The differential diagnosis for PRCA includes several conditions that can present with similar clinical features.

Congenital Red Cell Aplasia (Diamond-Blackfan Anemia): This is a congenital form of PRCA, characterized by normocytic and normochromic anemia, reticulocytopenia, and absent or infrequent erythroblasts in the bone marrow [4]. It is essential to distinguish this condition from acquired PRCA.

Parvovirus B19 Infection: Parvovirus B19 infection can cause a transient aplastic crisis, which presents with normocytic anemia, reticulocytopenia, and absent or infrequent erythroblasts in the bone marrow [9]. This condition should be considered in the differential diagnosis of PRCA.

Thymoma-Associated Pure Red Cell Aplasia: Thymoma-associated PRCA is a rare condition characterized by normocytic anemia, reticulocytopenia, and absent or infrequent erythroblasts in the bone marrow [10]. It is essential to consider this condition in the differential diagnosis of PRCA.

Other Conditions: Other conditions that can present with similar clinical features to PRCA include aplastic anemia, myelodysplastic syndromes, and certain infections [5][6].

In summary, the differential diagnosis for Pure Red Cell Aplasia includes congenital red cell aplasia (Diamond-Blackfan Anemia), parvovirus B19 infection, thymoma-associated PRCA, and other conditions that can present with similar clinical features.

References:

[1] PRCA is a rare disorder characterized by anemia due to failure of erythropoiesis. [2] Normocytic and normochromic anemia, reticulocytopenia, and absent or infrequent erythroblasts in the bone marrow are characteristic features of PRCA. [3] Congenital red cell aplasia (Diamond-Blackfan Anemia) is a congenital form of PRCA. [4] Parvovirus B19 infection can cause a transient aplastic crisis, which presents with normocytic anemia, reticulocytopenia, and absent or infrequent erythroblasts in the bone marrow. [5] Thymoma-associated PRCA is a rare condition characterized by normocytic anemia, reticulocytopenia, and absent or infrequent erythroblasts in the bone marrow. [6] Other conditions that can present with similar clinical features to PRCA include aplastic anemia, myelodysplastic syndromes, and certain infections.

Additional Differential Diagnoses

  • Myelodysplastic Syndromes
  • Congenital Red Cell Aplasia (Diamond-Blackfan Anemia)
  • Parvovirus B19 Infection
  • Thymoma-Associated Pure Red Cell Aplasia
  • Certain Infections
  • aplastic anemia

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
IAO_0000115
A congenital hypoplastic anemia that is characterized by a normocytic normochromic anemia with severe reticulocytopenia and marked reduction or absence of erythroid precursors from the bone marrow.
oboInOwl#id
DOID:1340
core#notation
DOID:1340
oboInOwl#hasDbXref
UMLS_CUI:C0034902
oboInOwl#hasExactSynonym
Red cell hypoplasia
rdf-schema#label
pure red-cell aplasia
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_1339
relatedICD
http://example.org/icd10/D60.9
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_8480
owl#annotatedSource
t403372

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.